1h Free Analyst Time
Technological advances to drive growth in the market. Technological advances such as the introduction of quadripolar lead devices, improvements in patient monitoring to avoid needless shocks, and development of MRI safe ICDs have significantly improved the reliability and effectiveness of ICDs. The analysts have predicted that the implantable cardioverter defibrillators market will register a CAGR of almost 2% by 2022.
Speak directly to the analyst to clarify any post sales queries you may have.
Market Overview
Increasing prevalence of cardiac arrhythmias
Prevalence of cardiac arrhythmias is steadily increasing. With the rise in cardiac disorders the demand for implantable cardioverter defibrillators will also increase.
Device limitations and complications
ICDs have been associated with many undesirable effects such as lead failures, deterioration in the quality of life, repeated in appropriate shocks, and premature battery complications.
For the detailed list of factors that will drive and challenge the growth of the implantable cardioverter defibrillators market during the 2018-2022, view this report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Abbott and BIOTRONIK, the competitive environment is quite intense. Factors such as the technological advances and the increasing prevalence of cardiac arrhythmias, will provide considerable growth opportunities to implantable cardioverter defibrillators manufactures. Abbott, BIOTRONIK, Boston Scientific, and Medtronic are some of the major companies covered in this report.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGYPART 09: CUSTOMER LANDSCAPEPART 11: DECISION FRAMEWORK
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 08: MARKET SEGMENTATION BY END-USER
PART 10: REGIONAL LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
List of Exhibits
Executive Summary
Global Implantable Cardioverter Defibrillators Market 2018-2022The analyst recognizes the following companies as the key players in the global implantable cardioverter defibrillators market: Abbott, BIOTRONIK, Boston Scientific, and Medtronic.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the technological advances.”
According to the report, one of the major drivers for this market is the increasing prevalence of cardiac arrhythmias.
Further, the report states that one of the major factors hindering the growth of this market is the device limitations and complications.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott
- BIOTRONIK
- Boston Scientific
- Medtronic
![Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator, Subcutaneous Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Therapy Defibrillator]: Global Opportunity Analysis and Industry Forecast, 2020-2030 - Product Image](http://www.researchandmarkets.com/product_images/12257/12257641_60px_jpg/implantable_defibrillators_market.jpg)
